Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

Srikanth Bellary; Abd A Tahrani; Anthony H Barnett

doi:10.1016/S2213-8587(20)30301-6

Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

Srikanth Bellary
, Abd A Tahrani
, Anthony H Barnett

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; Centre for Endocrinology Diabetes and Metabolism (CEDAM), Birmingham Health Partners, Birmingham, UK.
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	870-871
Number of pages	2
Journal	The Lancet Diabetes and Endocrinology
Volume	8
Issue number	11
Early online date	21 Sept 2020
DOIs	https://doi.org/10.1016/S2213-8587(20)30301-6
Publication status	Published - Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2213-8587(20)30301-6

Cite this

@article{b92aa0a829ea48aebfa134c611f6a7cc,

title = "Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?",

author = "Srikanth Bellary and Tahrani, \{Abd A\} and Barnett, \{Anthony H\}",

year = "2020",

month = nov,

doi = "10.1016/S2213-8587(20)30301-6",

language = "English",

volume = "8",

pages = "870--871",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",